RussianPatents.com

Immunostimulating drug

Immunostimulating drug
IPC classes for russian patent Immunostimulating drug (RU 2510277):
A61P37/04 - Immunostimulants
A61K36/185 - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L)
Another patents in same IPC classes:
Method of treating lichen acuminatus in oral mucosa / 2510269
Invention refers to medicine and aims at treating the patients with lichen acuminatus in an oral mucosa. The method involves using a conventional integrated therapy: vitamins, antihistaminic agents and anxiolytics. With underlying the therapy, from the first therapeutic day, the immunomodulator 12.5% neovir 250 mg is introduced intramuscularly once a day every 48 hours between the single doses in the amount of 5-10 injections per one course.
Vaccine composition applicable in hpv and hepatitis virus infections, and method for preparing it Vaccine composition applicable in hpv and hepatitis virus infections, and method for preparing it / 2509570
Invention refers to medicine, namely to biopharmaceutics, and may be used for preparing a chimeric vaccine for preventing human papilloma virus (HPV) and an infection caused by hepatitis B in a human. For this purpose, the vaccine contains an antigenic composition consisting of chimeric fusion molecules of polypeptides or epitopes of L1 and L2 HPV capsid antigen proteins with a hepatitis B surface antigen (HbsAg) as disclosed in SEQ ID NO: 3 to SEQ ID NO: 13.
Method for preparing therapeutic hydrogel / 2508091
Invention refers to medicine, namely to a method for preparing a therapeutic hydrogel material involving mixing an aqueous solution of sodium alginate and a drug preparation, dispersing a cross-linking agent that is presented by calcium sulphate in glycerol in the concentration of 0.8-2.5%, mixing the dispersion with the prepared mixture of sodium alginate with the drug preparation in ratio 1-2:4-6, placing the prepared product into a tiling pattern and keeping it till form-stable, conducting gamma sterilisation; the formation process involves the mechanical stability measurements with the diametral compression of the formed hydrogel; the hydrogel is considered to be formed once a thickness of the formed hydrogel varies with the diametral compression by 10-30%.
Method for preparing vaccine composition containing at least one antigen and at least one adjuvant Method for preparing vaccine composition containing at least one antigen and at least one adjuvant / 2500421
Group of inventions refers to biotechnology and immunology. What is presented is a method for preparing a vaccine with using reverse latex. The first stage involves preparing an adjuvant composition by dispersion of reverse latex or polymer powder prepared by reverse latex spraying, in a physiologically acceptable solution. The second stage involves mixing the prepared adjuvant composition with an antigen-containing medium for preparing the vaccine composition.
Immunomodulatory extracts of bacteria lactobacillus and methods for preparing and using them Immunomodulatory extracts of bacteria lactobacillus and methods for preparing and using them / 2500412
Invention refers to pharmaceutical industry, namely to an extract of one or more bacterial strains Lactobacillus. The extract of one or more bacterial strains Lactobacillus representing a soluble extract, wherein the extract contains chemically modified bacterial molecules prepared by the action of an alkaline medium on one or more bacterial strains Lactobacillus; the extract is effective in treating diseases associated with the anti-inflammatory cytokine production imbalance. A method for preparing the extract of one or more bacterial strains Lactobacillus. A pharmaceutical composition effective for reducing at least one symptom associated with at least one condition specified in a respiratory disorder, an allergic condition, an urinary disorder and a gastric disorder, containing the extract. A nutritional composition. A pharmacological composition effective in treating the diseases associated with the anti-inflammatory cytokine production imbalance, containing the extract. A method of relieving the above symptoms. The extract prepared by the above method.
Compositions and methods for using ca9 protein for immune system stimulation Compositions and methods for using ca9 protein for immune system stimulation / 2497543
Group of inventions refers to medicine, namely immunology and may be used for immune system stimulation. That is ensured by administering a composition containing a complex of isolated carbonic anhydrase IX (CA9) protein and an antigen, wherein the isolated CA9 proteins and the antigen are noncovalently linked to each other, into an individual. The group of inventions also refers to a composition containing a purified population of dendrite cells coming into contact with the above composition.
Pharmaceutical composition of pattern-recognising receptor ligands, methods for using it as immunostimulant for treating infection caused by bacterial and viral pathogens, method for using it as adjuvant of vaccines Pharmaceutical composition of pattern-recognising receptor ligands, methods for using it as immunostimulant for treating infection caused by bacterial and viral pathogens, method for using it as adjuvant of vaccines / 2497541
Group of inventions refers to pharmacology and medicine and concerns an immunostimulating composition, and methods for using it for enhancing the immune response, particularly for treating infections caused by bacterial and viral pathogens, to adjuvant compositions and methods for enhancing the antigen immunogenicity when used as an adjuvant of vaccines. The pharmaceutical composition of pattern-recognising receptor ligands contains muramyl peptide of structural formula N-acetylmuramyl-L-alanyl-D-isoglutamine and lipopolysaccharide or lipid A in the following proportions, wt %: muramyl peptide of structural formula N-acetylmuramyl-L-alanyl-D-isoglutamine 0.00001 to 0.01, lipopolysaccharide or lipid A 0.00001 to 0.01, a solvent - the rest.
Method of treating chronic bronchitis in patients with accompanying secondary immunodeficiency / 2496527
Invention refers to medicine, namely to pulmonology and may be used in treating the patients with chronic bronchitis in combination with secondary immunodeficiency. For this purpose, the patient with the remitting disease undergoes 6 procedures of ozone therapy every second days by the intravenous introduction of ozonised physiological saline with the ozone concentration 600 mcg/l in the ozone-oxygen gas mixture. One week after the ozone therapy, patient's venous blood is sampled and exposed to UV light for 2 procedures every 7 days. At the first procedure, the blood volume to be exposed makes 0.8 ml/kg of patient's body weight, and at the second procedure - 1 ml/kg.
Probiotics for improving tga secretion in infants born by caesarean section / 2496505
Invention refers to pharmaceutical industry and represents using probiotic bifidus bacteria in preparing a nutritional composition for improving IgA secretion in the infants born by cesarean section for the first four months of life.
Neisseria vaccine compositions containing antigen combination Neisseria vaccine compositions containing antigen combination / 2494758
Given invention refers to medicine, biopharmaceutics, and may be used to prepare vaccines. For this purpose, the immunogenic composition contains: 1) an antigen Neisseria autotransporter protein representing NadA or Hsf; 2) an antigen Neisseria protein involved in iron absorption and representing Lipo28 or low-molecular or high-molecular TbpA; and 3) a vesicle preparation of an outer membrane containing immunotype L3 Neisseria lipopolysaccharide (LPS); and wherein the above antigens if present in the outer membrane vesicle are positively regulated in accordance with recombinant technology in the above outer membrane vesicle.
Method for preparing pectin gel of elevated part of willow herb / 2510275
Invention refers to a method for preparing a pectin gel of an elevated part of willow herb. The declared method enables dissolving pre-recovered pectin from the elevated part of willow herb in water, cooling and applying onto a frozen chitosan solution and further gel formation.
Oral composition / 2510262
Group of inventions refers to medicine, namely to dentistry, and may be used as an oral composition for controlling an oral sweetener release. The above composition contains a polymer attached to the sweetener by a breakable link comprising a covalent bond, an ester bond or an amide bond. The breakable link is breakable in the oral cavity to release the sweetener. Said polymer is a polymer adhered to the mucosa and specified in methyl vinyl ether/maleic anhydride copolymer with polymer found in the amount of 0.001% to 10%. The sweetener is specified in dextrose, saccharose, maltose, dextrin, dried invert suger, mannose, xylose, ribose, fructose, lexulose, galactose, corn syrup, partially hydrolysed starch, sorbitol, mannitol, isomalt, aspartame, neotame, saccharine and its salts, sucralose, the sweeteners on the basis of dipeptides, cyclamates, dihydrochalcone with the sweetener content making 0.005% to 5%. What is also presented is a portable dispenser, a method for preparing the oral composition, a method for controlling the sweetener in the oral cavity, and using the polymer.
Composition for treating and preventing osteoarthritis and osteoarthrosis / 2509569
Invention refers to pharmaceutical industry, namely to a composition for treating and preventing osteoarthritis and osteoarthrosis. The composition for treating and preventing osteoarthritis and osteoarthrosis contains a powder or an extract of a dry plant specified in a group: burdock, dandelion, cowberry, birch, St.-John's wort, golden-rod, nettle, peppermint, licorice, cinquefoil, tormentil, brier, Greek valerian, valerian, corn, holy thistle, oat, agrimony, everlasting flower, ginseng, sage, starwort, squash, willow, wild strawberry, chicory, wheat-grass, artichoke, bilberry, marigold, horse radish, garlic, aspen, knotgrass, plantain, inula, Fagopyrum rubricaulis, chamomile, balm lemon, blue poppy, cudweed, tripartite bur-marigold; a male larval bee lyophilisate and a quercetine or dihydroquercetine, or rutin powder in certain proportions.
Method for correction of total blood serum baee-esterase activity using soya protein isolate / 2509568
Method refers to preventive medicine and concerns decreasing total BAEE-esterase activity. For this purpose, soya protein isolate 30 gram has been daily introduced into the subjects for 2 months.
Method for preparing cake shelf fungus extract / 2509567
Invention refers to pharmaceutical, food and cosmetic industry and concerns preparing a cake shelf fungus extract. The method for preparing the cake shelf fungus extract involving freezing cake shelf fungus, wetting it with a water solution containing dimethyl sulphoxide and sodium hydroxide, with a solution temperature being 50-90°C, and keeping at the above temperature for 1-2 hours.
Compositions of borinic acid Compositions of borinic acid / 2509553
Invention refers to pharmaceutical industry and represents an oral care composition having pH min. 8 or buffered so that to maintain the pH value min. 7, containing 3- hydroxypyridine-2-carbonyloxy-bis-(3-chlor-4-methylphenyl)borane in a combination or together with an orally acceptable carrier.
Composition applicable as personal hygiene product and methods for using it Composition applicable as personal hygiene product and methods for using it / 2509552
Invention refers to cosmetology and represents a composition applicable by a user as a personal hygiene product in the form of a bath or shower gel, containing: (a) no more than 11.5 wt % of an anionic surfactant representing alkyl sulphate, alkyl sarcosinate, or any combination thereof; (b) no more than 3 wt % of a zwitterionic surfactant representing fatty acid amidoalkylbetaine, (c) not less than 0.1 wt % of a hydroxyalkylcellulose derivative with a long-chain alkyl group; and (d) water.
Method of human health improvement / 2509547
Invention refers to medicine, namely recreation therapy, and may be used for human health improvement. That is ensured by traditional medical examination of the patient. The findings are used to draw up the rehabilitation program including body cleansing, intestine and liver purification, physical exercises. One week before the beginning of the rehabilitation program, the patient starts separate nutrition with preferential vegetable food and dairy products, limited consumption of salt, alcohol and sugar. One day before the rehabilitation program, a fasting day is kept with taking 1% kephir or fresh apple juice. Further, on the first two days of the three-day program or on the first four days of the seven-day program, the body is cleansed by keeping a juice diet. The juice diet contains fresh vegetable and fruit juices, herbal infusions and mineral water. Water is unlimited. On the first day of the cleansing program, the intestine is purified with the preparation Fortrans. Starting from the first day the liver and gall bladder are cleansed with using herbal and saline choleretics for four days of the 7-day program and for two days of the 3-day program. That is combined with paradoxical respiration by Strelnikova's technique and hydrotherapy. Physical exercises involve physical loads on a cardio-vascular machine, one training as prescribed by the doctor - yoga, pilates, chi gong, water aerobics or hypoxi capsule. Therapeutic massage and lymph drainage massage follow. Then body-detox, ozone therapy, collagenarium procedures are performed. Cold training procedures involve Linear Kneipp, saunas, swimming pool, turpentine bathes. Bathing and cold training procedures are followed by pilling and algae wraps. From the 5th day of the 7-day program, or from the 3rd day of the 3-day program, the diet involves water cereals, vegetable and fruit salads, vegetable fast soups.
Adhesive ointment for treating oral mucosal involvements in lichen acuminatus / 2508120
Invention refers to pharmaceutical industry, namely to an agent for treating an oral mucosal involvement accompanying lichen acuminatus. An adhesive ointment for treating the oral mucosal involvements accompanying lichen acuminatus containing sea buckthorn oil and 0.5% prednisolone ointment, socoseryl dental adhesive paste and vitamin A in the specific proportions.
Herbal trematocidal drug for excysted larvae fasciola hepatica / 2508119
Invention refers to pharmaceutical industry, particularly to using common dandelion herb as a trematocidal drug for excysted larvae Fasciola hepatica.
/ 2245143

FIELD: medicine.

SUBSTANCE: invention refers to an immunostimulating drug on the basis of a herbal alcohol tincture. The above drug is prepared by filling the herbal raw material with 70% ethanol in the ratio of 1:10, keeping in a dark place at temperature 18-20°C for 7 days, filtering, extracting the raw material, and filtering the extract. The herbal raw material contains purple Echinacea herb and blossom clusters, Scotch pine buds, horseheal roots and rhizomes, common licorice roots and harmel herb taken in 1:1:1:1:0.5.

EFFECT: drug possesses the manifested stimulating effect on the immune competent systems that promotes a higher level of the non-specific animal's protection.

1 tbl, 1 ex

 

The invention relates to veterinary medicine, refers to the means of natural origin and can be used for stimulation factors of immunity and natural resistance in farm animals.

Known drugs with similar action: drugs of biogenic origin, Zymosan (polysaccharides derived from yeast culture); Propolis; Apilak; Ribomunyl (bacterial ribosomes); Bronchosan (lyophilized bacteria); Pasat (combined preparation of autolysates bacteria); Thymalin, Taktivin, Timoptic, Timogen - solutions and lyophilisate for subcutaneous and intramuscular injection, and others; preparations obtained by the method of chemical synthesis Methyluracil, Stronger (stimulants leucopoiesis); Mildronate (similar to carnitine, has an anabolic effect); Arbidol (antiviral agent); Leucatin (pills and solution for injection); Diazepan (solution for injection); Decaris (pill) and others [1]; drugs of plant origin extract eleuterokkoka, aloe, ginseng extract, Immunal (juice of Echinacea purpurea); Tonsillar (combined preparation from plants) [2].

However, for these drugs there are some contraindications, one of which is individual sensitivity, in particular to some immunokorrigiruyuschy is redstem synthetic origin. In addition, the use of funds derived from animal tissue, partially because of the possible presence of prion new forms of pathogens that do not have genome and which are, in fact, infectious proteins that cause fatal slowly progressive degenerative brain diseases. Another limitation is the well-known unpredictability of the actions of some of immunotropic drugs, which, being appointed for one purpose, can lead to undesirable consequences type of autoimmune disorders, allergies or lampropeltis reactions.

Closest to the proposed action is a product of plant origin - Immunal (drops for internal use, consisting of juice, squeezed from freshly blooming plants of Echinacea purpurea (Echinacea purpurea L). However, the effect of this drug is limited, as it contains only one Echinacea purple as the main component.

A new technical challenge is expanding Arsenal of drugs with a higher degree of immunomodulator activity and giving when using fewer complications.

The problem is solved a new immunostimulating agent-based alcohol tinctures obtained from the grass and blossoms of purple coneflower (Echinacea purpurea (L), kidney pine ordinary is vannoy (Pínus sylvéstris), the roots and rhizomes of elecampane {Inula helenium), roots of licorice (Glycyrrhiza glabra L.) and grass Rue ordinary (Peganum harmala), taken in the ratio 1:1:1:1:0,5.

The chemical composition of the proposed medicinal product is presented as a complex of biologically active substances, which ensures its high therapeutic effect [2].

The predominant biologically active substances are: polysaccharides, flavonoids, phenol carbonic acids, triterpene saponins, vitamins, trace elements.

Polysaccharides have immunocorrigirutee, anti-inflammatory and antiviral effects. They stimulate nonspecific immunity and phagocytosis activity of macrophages and neutrophils, as well as bactericidal function of cells. In addition, include specific immune protection, increasing the number of T-lymphocytes, cytokine production, and reduce the activity of hyaluronidase produce bacteria and viruses. The result is stored hyaluronic acid - a substance that is formed in the tissues between cells and serves as a barrier against infections [3].

The flavonoids inherent hepatoprotective properties, which include Polyana holocaustmuseum, anti-inflammatory and capillary components, flavones and balcony possess bacteriostatic property, as well as tor Oset the formation of products of lipid peroxidation (diene conjugates, malondialdehyde, Schiff bases); they have the ability to normalize lipid metabolism in the liver, in particular its phospholipid fraction [4]. Preventing the accumulation of Mesopotamian, show antiphospholipid activity. In addition, flavonoids have antimicrobial, hypolipidemic, membrane stabilizing and antioxidant properties. Included in the collection of the flavonoid quercetin has the property to block the Na+, K+ and mitochondrial (Ca2+)-ATPase and the secretion of histamine mast cells. I believe that the mechanism of action of flavonoids on fat cell is of great importance to their affinity to specific phospholipid components of cell membranes [5].

Tannins (kidney pine up to 5%, Glycyrrhiza glabra - to 9.46%, elecampane - 9,3%), which is dominated by polyphenols have anti-inflammatory, antimicrobial properties and also have antioxidant and antitoxic effect [5].

Anti-inflammatory and anti-allergic properties due to the presence of triterpene saponins: glycyrrhizin (GL) and glycyrrhetinic acid. Ledger on the structure of the aglycone and metabolite glycyrrhetic acid has similarities with the structure of glucocorticoid hormones. The effect of the latter depends on the presence of group - and - uncertain ket is on, oxygen function at C11and Catalinas group in the side chain. The first two element patterns corticoid hormones have glycyrrhetic acid [4].

The high content of ascorbic acid {Echinacea - up to 4.0%), licorice - 3.0% of the buds of Scots pine - 0,3%) stimulates adrenal function, increasing the secretion of cortisol, causing anti-inflammatory and antiallergic effect.

Ions of manganese (manganese content, µg/g: Rue ordinary - 5,8, kidney pine - 88,0) are members of various enzyme systems, affect hematopoiesis, the function of liver cells, the tone of blood vessels, bile ducts, can prevent the formation of intravascular thrombi. Organic salts of iodine (iodine, mcg/g: licorice - 0,09; kidney pine - 0,15) improve protein assimilation, the assimilation of phosphorus, calcium and iron. The trace element zinc (zinc, ug/g; kidney pine - 31,10, licorice is 0.33, Rue ordinary - 0,78, elecampane - 0,27) participates in the body's immune processes, selenium (selenium, ug/g: licorice - 17,1, elecampane - 10,0, Rue ordinary - 1,0, kidney pine - 0,20) is a powerful antioxidant, iron (iron content, mg/g: Echinacea - 0,48, Rue ordinary to 0.14, elecampane is K - 0,9, licorice - 0,7, kidney pine - 0,04) is the main structural component of hemoglobin and hem-comprising enzyme, its salts normalize the body's lipid metabolism and have a stimulatory effect on erythropoiesis. as well as in complex with cobalt (cobalt, ág/g: licorice - 0,03, Rue ordinary - 0,4) has a stimulating effect on the immunogenesis in viral infections, copper (copper content, mg/g: kidney pine - 6.8, elecampane - 1,1, licorice - 0.2, Rue ordinary - 0,37) increases the functional activity of leukocytes, the authors estimated the effect of bactericidal activity of serum.

An example of obtaining the proposed immunostimulating agent.

0.45 kg of air-dry collection is crushed to a particle size of 3 mm, Then the crushed Assembly using a sieve with the hole diameter of 0.25 mm free from dust (particles less than 0.25 mm) and receive 0.45 kg of ready raw materials (consumable coefficient equal to 1.03), which is placed in the vessel of dark glass, pour 4500 ml of 70%ethanol, incubated in the dark at a temperature of 18-20°C for 7 days and filtered through the canvas, pressing the raw material. Immunostimulatory agent applied in the form of 7-8% aqueous solution

Clinical evaluation of immunostimulatory funds held in clinically healthy calves 20-30 days in the Rasta. Was formed two groups of animals 10 animals each (1-experienced introduced immunostimulatory agent in the form of a 7%aqueous solution at a dose of 2.5 ml/kg body weight for 10 days, group 2 was experienced). In the beginning of the experiment conducted screening blood tests for the selection of animals in the experience with the imbalance in the immune system (table), later (after 7 days) tracked changes occurring in the body of calves on the following indicators: functional activity of blood neutrophils, bacteria (BASK) and Lisitsina (FOREPLAY) activity of blood serum, the relative and absolute number of T - and b-lymphocytes, immunoglobulin level.

Background studies (table) revealed that indicators of immune reactivity in animals identified: insufficient level of immunoglobulins G and M, the lowest concentration which shows immunodeficient condition, imbalance in cellular and humoral immunity.

Table
The effectiveness of an immunostimulating agent for secondary immunodeficiency calves:
Indicators Groups of animals
Experienced Control
T-lymphocytes, %
T-lymphocytes, 109/l
B-lymphocytes, %
B-lymphocytes, 109/l
The functional activity of blood neutrophils, %
spontaneous test
- induced test
Immunoglobulins (mg/ml
- IgG
-
IgM
The authors estimated the effect activity of blood serum, %
Bactericidal activity of blood serum, %
Note: numerator - indicators to experience (background), the denominator is the value after 7 days of experience

When comparing parameters BASK in the dynamics of the experience, it was noted that by the end of this experiment show the tel in the experimental calves was significantly higher than in control animals (98,3±2.2% against 80,4±1,9%), TENDERNESS in the experimental group in contrast to the control animals reached lower values of the norm. The analysis of the research data of the cellular and humoral immunity is established that the application of the proposed funds contributed to significant increase in T - and b-lymphocytes. In the experimental group relative number of T cells were 31.0±1.2%, In cells and 8.6±0.4%, while the control animals relative number of T - and b-lymphocytes was 24.2±0,4% and 6.0±0.7%, respectively. In the humoral immunity was determined the content of the classes of immunoglobulins G and M in all the experimental animals. Analysis of these data allowed us to conclude that the tool contributed to significant increase in Ig G (15,0±0.1 mg/ml against 12,8±0.7 mg/ml in control), and the concentration of Ig M a tendency to increase.

The proposed tool containing alcohol tincture medicinal plant collection, is a means of natural origin, made from affordable, environmentally friendly raw materials, and its application has had a pronounced stimulating effect on the immune system of the body, resulting in increased levels of non-specific protection of the animal.

Sources of information

1. D.K. Novikov, Derkach YU.N., But what of Sri P.D. Immunotropic drugs // In the world of drugs. - M., 1999. - 2 (4). - P.48-58.

2. Bakuridze A. D., Kurtsikidze MS, Pisarev V.M. and other Immunomodulators of plant origin (review) // Chem. the pharmacist magazine. - M., 1993. - 8. - S.43-47.

3. Samorodov C. N., Pospelov ST., Moses GF and other Phytochemical composition of the genus Echinacea (Echinacea Moench.) and its pharmacological properties (review) // Chem. the pharmacist magazine. - M., 1996. - 4. - P.32-37.

4. Obolentseva, GV, Litvinenko VI, Ammosov A.S. and other Pharmacological and therapeutic properties of drugs licorice (review) // Chem. the pharmacist magazine. - M., 1999. - 8. - P.24-28.

5. Sokolov, SJ, zamotaev I.P. Handbook of medicinal plants. - M., 1990. - 464 S.

Immunostimulatory agent-based alcohol tinctures of medicinal plant collection, characterized in that as the plant materials used grass and clusters of purple coneflower (Echinacea purpurea L.)buds of Scots pine (Pinus sylvestris), roots and rhizomes of elecampane (Inula helenium), the roots of licorice (Glycyrrhiza glabra L.) and grass Rue ordinary (Peganum harmala), taken in the ratio 1:1:1:1:0,5, vegetable raw material is poured in ethyl alcohol 70%concentration at a ratio of 1:10, incubated in the dark at a temperature of 18-20°C for 7 days, filtered, pressing raw and filtered.

 

© 2013-2014 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English.